NASDAQ$CDNA

CareDx Inc · Q3 2019 earnings

Q3 2019 earnings · · Investor relations

Headline financials

Total Revenue

$33.8M

Previous: $21.2M+59.6%
EPS (adj)

$0.02

Previous: -$0.01+300.0%
Adjusted EBITDA

$800K

No prior period
Capital Expenditures

-$970K

Previous: -$1.08M+9.8%
Free Cash Flow

-$2.78M

Previous: -$21M+86.8%
Net Income

-$1.81M

Previous: -$20M+90.9%
Operating Income

-$6.75M

Previous: -$2.72M-148.1%
Gross Profit

$22.3M

Previous: -$224K+10062.9%
Cash & Equivalents

$40.9M

Previous: $26.2M+56.2%
Total Assets

$145M

Previous: $91.4M+58.4%
Stock-Based Comp

$5.97M

Previous: $1.86M+220.5%

Revenue & EPS history

CareDx · Revenue · Quarterly

$33.8M

Q3 2019+59.6%vs Q3 2018
Beat estimate in 8 of 16 quarters(50%)
ActualEstimate

Revenue by segment

CareDx · $33.8M total across 3 segments · Q3 2019

  • Testing Services
    $28.2M
  • Product Revenue
    $4.2M
  • Patient and Digital Solutions
    $1.4M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2019

Historical avgQ3 2019

+2.4%

Avg return

Earnings day

+0.1%

Avg return

5 days after

+7.1%

Avg return

30 days after

54%

28 / 52 earnings

Positive

+45.7%

Q1 2024

Best reaction

-24.3%

Q3 2021

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.3%-1.6%+3.8%
Q4 2025-4.3%-2.6%-12.8%
Q3 2025-1.8%+5.8%+31.4%
Q1 2025-10.7%-16.0%+0.7%
Q4 2024-0.2%-3.8%-14.9%
Q3 2024+1.1%+4.5%+14.5%
Q2 2024+25.7%+26.3%+63.8%
Q1 2024+45.7%+49.7%+49.4%
Q4 2023+12.1%+27.3%+11.6%
Q3 2023+8.7%+19.5%+48.0%
Q2 2023-9.3%-17.6%-23.5%
Q1 2023-2.0%-2.2%-8.7%
Q4 2022+16.4%-37.9%-37.0%
Q3 2022-16.5%-14.4%-31.1%
Q2 2022+7.7%-4.2%-25.2%
Q1 2022-24.3%-32.1%-23.9%
Q4 2021+10.3%+7.2%+6.6%
Q3 2021-24.3%-26.9%-37.1%
Q2 2021-2.5%-4.9%-7.4%
Q1 2021-1.9%-10.0%+9.3%
Q4 2020+2.7%+13.2%-20.3%
Q3 2020-3.1%-2.4%+13.5%
Q2 2020+5.2%-0.9%-4.3%
Q1 2020-0.0%+9.6%+19.6%
Q4 2019-5.6%-13.2%-11.5%
Q3 2019-11.8%-23.8%-21.6%
Q2 2019+6.8%-15.7%-30.4%
Q1 2019+15.0%+12.6%+30.6%
Q4 2018+7.5%+10.2%-10.1%
Q3 2018-9.8%-10.2%-6.0%
Q2 2018+15.3%+14.6%+73.1%
Q1 2018-2.1%-2.6%+35.1%
Q4 2017+24.1%+28.5%+51.8%
Q3 2017+6.2%+6.6%+31.0%
Q2 2017+9.2%+26.8%+109.9%
Q1 2017-4.6%-3.7%+14.7%
Q4 2016+5.1%-12.2%+13.7%
Q3 2016+1.3%+3.9%-24.7%
Q2 2016-1.0%-2.9%-5.3%
Q1 2016+6.0%
Q4 2015+7.7%
Q3 2015+5.0%
Q2 2015-1.6%
Q1 2014-0.4%
Q1 2015-0.8%
Q4 2012+0.5%
Q4 2014-1.8%
Q3 2013-1.0%
Q3 2014+17.2%
Q2 2013+0.2%
Q4 2013+0.2%
Q2 2014+1.9%
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro